1Paffen E, DeMaat MP. C-reactive protein in atherosclerosis: a causal factor? [J]. Cardiovasc Res, 2006, 71:30-39.
2Garau A, Bertini R, Colotta F, et al. Neuroprotection with the CXCL8 inhibitor repertaxin in transient brain ischemia[J]. Cytokine, 2005, 30:125-131.
3Suzuki S, Tanaka k, Suzuki N. Ambivalent aspects of interleukin-6 in cerebral ischemia: inflammatory versus neurotrophic aspects[J]. J Cereb Blood Flow Metab, 2008. [Epub ahead of print].
4Nakase T,Yazamaki T, Oqura N, et al. The impact of inflammation on the pathogenesis and prognosis of ischemic stroke[J]. J Neurol Sei, 2008, 271 (1-2): 104-109.
5Terao S, Yilmaz G, Stokes KY, et al. Blood cell-derived RANTES mediates cerebral microvascular dysfunction, inflammation, and tissue injury after focal ischemia-reperfusion[J]. Stoke, 2008, 39: 2560- 2570.
6Newman MB, Willing AE, Manresa JJ, et al. Strokeinduced migration of human umbilical cord blood cells: time course and cytokines[J]. Stem Cells Dev, 2005, 14 : 576-586.
7Adibhatla RM, Hatcher JF, Larsen EC, et al. CDP-choline significantly restores phosphatidylcholine levels by differentially affecting phospholipase A2 and CTP: phosphocholine cytidylyltransferase after stroke [J]. J Biol Chem, 2006, 281: 6718-6725.
8Zhao BQ, Wang S, Kim HY, et al. Role of matrix metalloproteinases in delayed cortical responses after stroke[J]. Nat Med, 2006, 12: 441-445.
